749 A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIA clinical trial

JOURNAL OF HEPATOLOGY(2006)

引用 1|浏览7
暂无评分
关键词
clinical trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要